8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Humana reports higher second-quarter earnings but cuts 2026 GAAP EPS guidance
Filed with the SEC on · Summarized by InvestorsBot
Humana reported second-quarter 2026 revenue of $40.9 billion, GAAP EPS of $5.73 and adjusted EPS of $7.61 for the period ended June 30, 2026, compared with $4.51 and $6.27, respectively, a year earlier. The company affirmed adjusted 2026 EPS guidance of at least $9.00 and its 92.75% insurance benefit-ratio target, but lowered GAAP EPS guidance to at least $6.52 from at least $8.36, citing non-GAAP adjustment impacts and the Medicare Advantage Star Ratings headwind; it also expects individual MA membership to grow about 25% and CenterWell patient growth reached 130,900 year to date.